Relationship Between the Biomarkers of Collagen Regulation and Echocardiography Parameters in Patients With Heart Failure With Preserved Ejection Fraction

Aim. To study the relationship between laboratory markers and echocardiography (EchoCG) parameters in heart failure with preserved ejection fraction (HFpEF) depending on the results of the diastolic stress test (DST).

Material and methods. The diagnostic algorithm provided by the current guidelines for the assessment of left ventricular (LV) diastolic function was used to select patients. If there were not enough criteria to make a conclusion about increased LV filling pressure (FP) based on standard resting echocardiography data in patients with arterial hypertension and ischemic heart disease, DST was performed to detect HFpEF. 80 patients (50.0% men, mean age 66.3±5.4 years) were included. Group 1 consisted of 41 patients with a positive DST, and group 2 included 39 patients with a negative DST. Concentrations of the markers of immune inflammation, endothelial dysfunction, collagen homeostasis, and myocardial stress were measured.

Results. The DST showed significant differences in the E/e’ ratio (15.1 [13.4; 15.9] in group 1 and 9.5 [7.9; 10.3] in group 2, respectively, p<0.001) and the diastolic functional reserve index (DFRI) (9.8 [6.8; 14.0] and 21.0 [13.0; 29.0], p < 0.001). Resting EchoCG revealed significant differences in the left atrial reservoir strain (LASr) (22.8 [19.6; 25.6]% and 28.0 [24.8; 30.2]%, p<0.001) and the left atrial stiffness index (LASI) (0.50 [0.40; 0.57] and 0.34 [0.27; 0.41], p<0.001). In patients with HFpEF, the laboratory parameters of collagen regulation had the greatest number of relationships. Correlations were found between the concentrations of matrix metalloproteinase-9 and other biomarkers, including interleukin-10 (IL-10) (r=0.311; p=0.048), myeloperoxidase (r=0.382; p=0.014), N-terminal propeptide of procollagen type I (procollagen I N-terminal propeptide, PINP) (r=0.722; p<0.001) and type III (r=0.591; p<0.001), C-terminal propeptide of procollagen type I (r=0.330; p=0.035), tissue inhibitor of metalloproteinases type 1 (r=0.410; p=0.008), EchoCG parameters, including left atrial volume index (LAVI) (r=0.414; p=0.007) and DFRI (r=0.354; p=0.025). In addition, correlations were found for the concentrations of PINP with IL-10 (r=0.401; p=0.009) and endothelin-1 (r= -0.337; p=0.031); PINP with LAVI (r=0.498; p=0.001) and DFRI (r=0.420; p=0.007).

Conclusion. Patients with HFpEF have a greater number of relationships between markers of collagen homeostasis disorders and EchoCG parameters characterizing an increase in LV FP.

1. Zhang H, Dhalla NS. The Role of Pro-Inflammatory Cytokines in the Pathogenesis of Cardiovascular Disease. International Journal of Molecular Sciences. 2024;25(2):1082. DOI: 10.3390/ijms25021082

2. Paulus WJ, Zile MR. From Systemic Inflammation to Myocardial Fibrosis: The Heart Failure With Preserved Ejection Fraction Paradigm Revisited. Circulation Research. 2021;128(10):1451–67. DOI: 10.1161/CIRCRESAHA.121.318159

3. Bayes-Genis A, Cediel G, Domingo M, Codina P, Santiago E, Lupón J. Biomarkers in Heart Failure with Preserved Ejection Fraction. Cardiac Failure Review. 2022;8:e20. DOI: 10.15420/cfr.2021.37

4. Cohen JB, Schrauben SJ, Zhao L, Basso MD, Cvijic ME, Li Z et al. Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction. JACC: Heart Failure. 2020;8(3):172–84. DOI: 10.1016/j.jchf.2019.09.009

5. Ovchinnikov AG, Potekhina A, Belyavskiy E, Gvozdeva A, Ageev F. Left atrial dysfunction as the major driver of heart failure with preserved ejection fraction syndrome. Journal of Clinical Ultrasound. 2022;50(8):1073–83. DOI: 10.1002/jcu.23318

6. Shirokov N.E., Yaroslavskaya E.I., Krinochkin D.V., Musikhina N.A., Gizatulina T.P., Enina T.N. et al. Principles for diagnosing heart failure with preserved ejection fraction. Russian Journal of Cardiology. 2023;28(S3):68–76. DOI: 10.15829/1560-4071-2023-5448

7. Nagueh SF, Smiseth OA, Appleton CP, Byrd BF, Dokainish H, Edvardsen T et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. European Heart Journal – Cardiovascular Imaging. 2016;17(12):1321–60. DOI: 10.1093/ehjci/jew082

8. Lancellotti P, Pellikka PA, Budts W, Chaudhry FA, Donal E, Dulgheru R et al. The Clinical Use of Stress Echocardiography in Non-Ischaemic Heart Disease: Recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Journal of the American Society of Echocardiography. 2017;30(2):101–38. DOI: 10.1016/j.echo.2016.10.016

9. Pieske B, Tschöpe C, de Boer RA, Fraser AG, Anker SD, Donal E et al. How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). European Heart Journal. 2019;40(40):3297–317. DOI: 10.1093/eurheartj/ehz641

10. Ovchinnikov A.G., Ageev F.T., Alekhin M.N., Belenkov Yu.N., Vasyuk Yu.A., Galyavich A.S. et al. The role of diastolic transthoracic stress echocardiography with incremental workload in the evaluation of heart failure with preserved ejection fraction: indications, methodology, interpretation. Kardiologiia. 2020;60(12):48–63. DOI: 10.18087/cardio.2020.12.n1219

11. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography. 2015;28(1):1-39.e14. DOI: 10.1016/j.echo.2014.10.003

12. Badano LP, Kolias TJ, Muraru D, Abraham TP, Aurigemma G, Edvardsen T et al. Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. European Heart Journal - Cardiovascular Imaging. 2018;19(6):591–600. DOI: 10.1093/ehjci/jey042

13. Vlasov T.D., Petrischev N.N., Lazovskaya O.A. Endothelial dysfunction. Do we understand this term properly? Messenger of Anesthesiology and Resuscitation. 2020;17(2):76–84. DOI: 10.21292/2078-5658-2020-17-2-76-84

14. Cai Z, Wu C, Xu Y, Cai J, Zhao M, Zu L. The NO-cGMP-PKG Axis in HFpEF: From Pathological Mechanisms to Potential Therapies. Aging and disease. 2023;14(1):46–62. DOI: 10.14336/AD.2022.0523

15. Loperena R, Van Beusecum JP, Itani HA, Engel N, Laroumanie F, Xiao L et al. Hypertension and increased endothelial mechanical stretch promote monocyte differentiation and activation: roles of STAT3, interleukin 6 and hydrogen peroxide. Cardiovascular Research. 2018;114(11):1547–63. DOI: 10.1093/cvr/cvy112

16. Serezhina E.K., Obrezan A.G. Features of phenotyping patients with heart failure with preserved ejection fraction. Russian Journal of Cardiology. 2023;28(S3):77–82. DOI: 10.15829/1560-4071-2023-5348

17. Ageev F.T., Ovchinnikov A.G. Treatment of patients with heart failure and preserved ejection fraction: reliance on clinical phenotypes. Kardiologiia. 2022;62(7):44–53. DOI: 10.18087/cardio.2022.7.n2058

18. Krebber MM, Van Dijk CGM, Vernooij RWM, Brandt MM, Emter CA, Rau CD et al. Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Extracellular Matrix Remodeling during Left Ventricular Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 2020;21(18):6742. DOI: 10.3390/ijms21186742

19. Steen EH, Wang X, Balaji S, Butte MJ, Bollyky PL, Keswani SG. The Role of the Anti-Inflammatory Cytokine Interleukin-10 in Tissue Fibrosis. Advances in Wound Care. 2020;9(4):184–98. DOI: 10.1089/wound.2019.1032

20. Sedaghat-Hamedani F, Kayvanpour E, Frankenstein L, Mereles D, Amr A, Buss S et al. Biomarker Changes after Strenuous Exercise Can Mimic Pulmonary Embolism and Cardiac Injury – A Metaanalysis of 45 Studies. Clinical Chemistry. 2015;61(10):1246–55. DOI: 10.1373/clinchem.2015.240796